David Stout

David Stout serves as the Director of Sales - Enterprise at mabl since April 2023, where the focus is on intelligent, low-code test automation solutions. David also engages as an investor in Renibus Therapeutics Inc, a clinical-stage biopharmaceutical company, and is an Advisory Board Member for OneShot.ai, concentrating on AI research and personalization. David's previous roles include Vice President of Sales at SeaLights and WhiteSource, where responsibilities included open-source management solutions, and Area Vice President Sales at CloudBees and Tata Consultancy Services, specializing in automation and AI solutions. David began a career at IBM, driving software sales and achieving significant revenue growth. David holds a Bachelor of Science in Leadership Development from Texas A&M University and an MBA from The University of Dallas.

Location

Argyle, United States

Links

Previous companies


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices


Rénibus Therapeutics

Rénibus Therapeutics is a biotech company dedicated to transforming the cardio-renal disease treatment paradigm by focusing on the prevention, treatment, and diagnostic testing of kidney disease.


Industries

Employees

51-200

Links